Actigraphic and self-reported characterization of sleep in systemic lupus erythematosus patients.
coping factors
immunosuppressants
nervous
quality of life
systemic lupus erythematosus
Journal
Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501
Informations de publication
Date de publication:
11 Jul 2023
11 Jul 2023
Historique:
received:
27
02
2023
revised:
09
06
2023
accepted:
27
06
2023
medline:
11
7
2023
pubmed:
11
7
2023
entrez:
11
7
2023
Statut:
aheadofprint
Résumé
In a cross-sectional study, we explored possible differences in sleep parameters between Systemic Lupus Erythematosus (SLE) patients and age- and gender-matched healthy controls through actigraphic and self-reported measures. Furthermore, we aimed at identifying possible predictors of such disturbances in the patients' cohort. Participants' sociodemographic data and sleep parameters were collected. Sleep parameters were evaluated through the Pittsburgh Sleep Quality Index, the Insomnia Severity Index (ISI) and a 7-day actigraphic monitoring. The Perceived Stress Scale-10 was used to investigate stress. Disease activity and daily glucocorticoid dose were assessed in SLE patients. Possible predictors of the SLE group were explored through two binomial logistic models. Within the SLE group, possible predictors of sleep parameters were tested estimating multiple linear regression models. 40 SLE patients and 33 controls were included in the study. SLE group showed worse sleep maintenance actigraphic parameters (i.e., sleep efficiency and wake after sleep onset), higher total sleep time and higher perceived stress. Within the SLE cohort, daily glucocorticoids dose was associated with an impairment in sleep maintenance despite no reduction in sleep duration, typical of normal sleep duration insomnia, whereas perceived stress was associated with short sleep duration insomnia. Compared to healthy controls, SLE patients showed worse sleep quality and greater perceived stress severity. As glucocorticoids and perceived stress promote different types of insomnia in these patients, a multidimensional approach to both sleep characterization and therapy might hence be preferred.
Identifiants
pubmed: 37432350
pii: 7222623
doi: 10.1093/rheumatology/kead344
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology.